$21.070
+0.335 (+1.59%)Al cierre
Noticias de PARK
Eventos de PARK
Company Updates FY26 Outlook, Adjusts EBITDA to $21M-$23M
Consensus $257.59M. Sees FY26 adjusted EBITDA $21M-$23M. The company said, "Based on our performance during the first half of 2026 and our current expectations for the remainder of the year, we are updating our full-year 2026 outlook. Our updated outlook does not contemplate the recently announced acquisition of Village Family Dental DSO, which remains subject to customary closing conditions and is expected to close later this year. Consistent with our historical approach, only completed acquisitions are incorporated into our outlook. Following the close of the transaction, we expect to evaluate its anticipated financial impact and provide an updated outlook at an appropriate time. Our revised outlook reflects continued confidence in the underlying performance of our affiliated practices, including patient demand, same-practice revenue growth, provider recruitment, and operational execution."
Company Reports Q2 Revenue of $66.21M
Reports Q2 revenue $66.21M, consensus $64.36M. "We delivered another quarter of revenue growth, supported by positive same-practice performance, strong patient retention, and continued expansion of our affiliated doctor base. Our underlying operations are preforming well and generated strong operating cash flows during the quarter.
Park Dental Partners Acquires Village Family Dental DSO
Park Dental Partners announced that it has entered into a definitive agreement to acquire Village Family Dental DSO. The Village Family Dental DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. Upon completion, the transaction would mark Park Dental Partners' expansion into its fourth state.
Company Reports Q4 Revenue of $61.2M, Up from $56.9M Last Year
Reports Q4 revenue $61.2M vs. $56.9M last year. Revenue growth was driven by increased patient visits, clinical hours, and fee and reimbursement growth, highlighted by same practice revenue growth of 6.3%. "We are pleased to report a strong finish to a very successful year. We achieved record revenue and adjusted EBITDA in 2025 and successfully completed our initial public offering in December," said CEO Pete Swenson.
Company Outlook Includes 3.5%-5.0% Same Practice Revenue Growth
The company's outlook includes 3.5%-5.0% same practice revenue growth and assumes continued patient demand and stable reimbursement trends across commercial and government payors.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.